C3 ( CTHR ) Diamond in the rough? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough?

CTHR 0.400

+263.6%

Oct 31 12:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dennis michael patterson who wrote (4)	11/15/1997 6:07:00 PM
From: glen	Read Replies (2) of 226

Leslie, The original "red herring" prospectus (as the initial one's are called) stated that 2 million shares would be issued at $13.50 /share. Increasing both the price and quantity changed it from a "hot" to a "cold", IPO. I cancelled my indication for C3 last Wednesday when I heard 3 million shares were to be sold. I would consider buying C3 on a dip. It does have long term potential to do well. I do view this, however, as a successful IPO, for both C3, and holders of CREE. Both companies will benefit from the capital that has been raised. It appears to me that the 3 Hunter brothers are attempting to work together in creating great value from their technology achievments in both of these companies. regards, glen

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next